Annual Retained Earnings
-$1.68 B
-$226.54 M-15.57%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual retained earnings is currently -$1.68 billion, with the most recent change of -$226.54 million (-15.57%) on 31 December 2023. During the last 3 years, it has fallen by -$657.72 million (-64.27%). BCRX annual retained earnings is now -7719.34% below its all-time high of -$21.50 million, reached on 31 December 1994.BCRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.74 B
-$14.03 M-0.81%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly retained earnings is currently -$1.74 billion, with the most recent change of -$14.03 million (-0.81%) on 30 September 2024. Over the past year, it has dropped by -$123.82 million (-7.65%). BCRX quarterly retained earnings is now -10727.61% below its all-time high of -$16.10 million, reached on 31 March 1994.BCRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -7.7% |
| 3 y3 years | -64.3% | -46.5% |
| 5 y5 years | -129.7% | -108.0% |
BCRX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.3% | at low | -46.5% | at low |
| 5 y | 5 years | -129.7% | at low | -108.0% | at low |
| alltime | all time | -7719.3% | at low | <-9999.0% | at low |
BioCryst Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.74 B(+0.8%) |
| June 2024 | - | -$1.73 B(+0.7%) |
| Mar 2024 | - | -$1.72 B(+2.1%) |
| Dec 2023 | -$1.68 B(+15.6%) | -$1.68 B(+3.8%) |
| Sept 2023 | - | -$1.62 B(+2.3%) |
| June 2023 | - | -$1.58 B(+5.0%) |
| Mar 2023 | - | -$1.51 B(+3.7%) |
| Dec 2022 | -$1.45 B(+20.5%) | -$1.45 B(+5.2%) |
| Sept 2022 | - | -$1.38 B(+3.2%) |
| June 2022 | - | -$1.34 B(+4.6%) |
| Mar 2022 | - | -$1.28 B(+6.1%) |
| Dec 2021 | -$1.21 B(+18.0%) | -$1.21 B(+1.5%) |
| Sept 2021 | - | -$1.19 B(+5.2%) |
| June 2021 | - | -$1.13 B(+4.0%) |
| Mar 2021 | - | -$1.09 B(+6.3%) |
| Dec 2020 | -$1.02 B(+21.7%) | -$1.02 B(+6.3%) |
| Sept 2020 | - | -$962.95 M(+5.0%) |
| June 2020 | - | -$916.83 M(+4.4%) |
| Mar 2020 | - | -$878.23 M(+4.5%) |
| Dec 2019 | -$840.63 M(+14.8%) | -$840.63 M(+0.3%) |
| Sept 2019 | - | -$838.01 M(+4.7%) |
| June 2019 | - | -$800.41 M(+4.9%) |
| Mar 2019 | - | -$762.78 M(+4.2%) |
| Dec 2018 | -$731.97 M(+15.8%) | -$731.97 M(+3.9%) |
| Sept 2018 | - | -$704.54 M(+4.4%) |
| June 2018 | - | -$674.94 M(+2.8%) |
| Mar 2018 | - | -$656.49 M(+3.9%) |
| Dec 2017 | -$631.84 M(+11.6%) | -$631.84 M(+3.2%) |
| Sept 2017 | - | -$612.30 M(+2.5%) |
| June 2017 | - | -$597.17 M(+2.9%) |
| Mar 2017 | - | -$580.28 M(+2.5%) |
| Dec 2016 | -$566.06 M(+10.8%) | -$566.06 M(+0.8%) |
| Sept 2016 | - | -$561.56 M(+2.1%) |
| June 2016 | - | -$550.03 M(+3.1%) |
| Mar 2016 | - | -$533.75 M(+4.5%) |
| Dec 2015 | -$510.92 M(+9.2%) | -$510.92 M(+3.7%) |
| Sept 2015 | - | -$492.78 M(+3.1%) |
| June 2015 | - | -$478.16 M(-1.0%) |
| Mar 2015 | - | -$483.06 M(+3.2%) |
| Dec 2014 | -$467.90 M(+10.7%) | -$467.90 M(+2.6%) |
| Sept 2014 | - | -$456.23 M(+2.0%) |
| June 2014 | - | -$447.50 M(+3.4%) |
| Mar 2014 | - | -$432.85 M(+2.4%) |
| Dec 2013 | -$422.71 M(+7.7%) | -$422.71 M(+1.3%) |
| Sept 2013 | - | -$417.28 M(+2.0%) |
| June 2013 | - | -$409.28 M(+3.1%) |
| Mar 2013 | - | -$397.11 M(+1.1%) |
| Dec 2012 | -$392.60 M(+11.1%) | -$392.60 M(+2.9%) |
| Sept 2012 | - | -$381.55 M(+2.6%) |
| June 2012 | - | -$371.85 M(+3.4%) |
| Mar 2012 | - | -$359.57 M(+1.7%) |
| Dec 2011 | -$353.52 M(+19.2%) | -$353.52 M(+3.9%) |
| Sept 2011 | - | -$340.33 M(+4.4%) |
| June 2011 | - | -$325.87 M(+5.3%) |
| Mar 2011 | - | -$309.60 M(+4.4%) |
| Dec 2010 | -$296.57 M(+12.9%) | -$296.57 M(+3.6%) |
| Sept 2010 | - | -$286.37 M(+3.9%) |
| June 2010 | - | -$275.51 M(+3.8%) |
| Mar 2010 | - | -$265.31 M(+1.0%) |
| Dec 2009 | -$262.72 M | -$262.72 M(-5.5%) |
| Sept 2009 | - | -$277.87 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | -$267.24 M(+3.4%) |
| Mar 2009 | - | -$258.56 M(+3.7%) |
| Dec 2008 | -$249.27 M(+11.0%) | -$249.27 M(-3.9%) |
| Sept 2008 | - | -$259.34 M(+3.6%) |
| June 2008 | - | -$250.34 M(+5.3%) |
| Mar 2008 | - | -$237.63 M(+5.8%) |
| Dec 2007 | -$224.54 M(+14.9%) | -$224.54 M(+1.0%) |
| Sept 2007 | - | -$222.25 M(+5.2%) |
| June 2007 | - | -$211.27 M(+3.4%) |
| Mar 2007 | - | -$204.31 M(+4.5%) |
| Dec 2006 | -$195.48 M(+28.7%) | -$195.48 M(+5.4%) |
| Sept 2006 | - | -$185.43 M(+9.2%) |
| June 2006 | - | -$169.83 M(+6.3%) |
| Mar 2006 | - | -$159.75 M(+5.2%) |
| Dec 2005 | -$151.86 M(+20.8%) | -$151.86 M(+4.9%) |
| Sept 2005 | - | -$144.70 M(+5.6%) |
| June 2005 | - | -$137.06 M(+4.3%) |
| Mar 2005 | - | -$131.41 M(+4.5%) |
| Dec 2004 | -$125.76 M(+20.2%) | -$125.76 M(+4.4%) |
| Sept 2004 | - | -$120.47 M(+4.6%) |
| June 2004 | - | -$115.18 M(+4.6%) |
| Mar 2004 | - | -$110.12 M(+5.2%) |
| Dec 2003 | -$104.66 M(+13.8%) | -$104.66 M(+3.2%) |
| Sept 2003 | - | -$101.41 M(+3.5%) |
| June 2003 | - | -$98.00 M(+3.4%) |
| Mar 2003 | - | -$94.75 M(+3.0%) |
| Dec 2002 | -$91.96 M(+22.6%) | -$91.96 M(+3.1%) |
| Sept 2002 | - | -$89.22 M(+4.0%) |
| June 2002 | - | -$85.81 M(+6.4%) |
| Mar 2002 | - | -$80.65 M(+7.5%) |
| Dec 2001 | -$75.03 M(+7.1%) | -$75.03 M(+7.1%) |
| Sept 2001 | - | -$70.05 M(-0.6%) |
| June 2001 | - | -$70.47 M(-1.3%) |
| Mar 2001 | - | -$71.43 M(+2.0%) |
| Dec 2000 | -$70.05 M(+19.7%) | -$70.05 M(+16.3%) |
| Sept 2000 | - | -$60.25 M(+2.8%) |
| June 2000 | - | -$58.60 M(+3.5%) |
| Mar 2000 | - | -$56.61 M(-3.2%) |
| Dec 1999 | -$58.50 M(+10.0%) | -$58.50 M(+0.9%) |
| Sept 1999 | - | -$58.00 M(+3.9%) |
| June 1999 | - | -$55.80 M(+0.4%) |
| Mar 1999 | - | -$55.60 M(+4.5%) |
| Dec 1998 | -$53.20 M(+9.9%) | -$53.20 M(+2.9%) |
| Sept 1998 | - | -$51.70 M(-5.0%) |
| June 1998 | - | -$54.40 M(+5.8%) |
| Mar 1998 | - | -$51.40 M(+6.2%) |
| Dec 1997 | -$48.40 M(+28.0%) | -$48.40 M(+6.4%) |
| Sept 1997 | - | -$45.50 M(+5.8%) |
| June 1997 | - | -$43.00 M(+5.1%) |
| Mar 1997 | - | -$40.90 M(+8.2%) |
| Dec 1996 | -$37.80 M(+25.6%) | -$37.80 M(+5.9%) |
| Sept 1996 | - | -$35.70 M(+7.9%) |
| June 1996 | - | -$33.10 M(+3.4%) |
| Mar 1996 | - | -$32.00 M(+6.3%) |
| Dec 1995 | -$30.10 M(+40.0%) | -$30.10 M(+7.9%) |
| Sept 1995 | - | -$27.90 M(+7.3%) |
| June 1995 | - | -$26.00 M(+6.6%) |
| Mar 1995 | - | -$24.40 M(+13.5%) |
| Dec 1994 | -$21.50 M | -$21.50 M(+9.7%) |
| Sept 1994 | - | -$19.60 M(+8.9%) |
| June 1994 | - | -$18.00 M(+11.8%) |
| Mar 1994 | - | -$16.10 M |
FAQ
- What is BioCryst Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual retained earnings year-on-year change?
- What is BioCryst Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly retained earnings year-on-year change?
What is BioCryst Pharmaceuticals annual retained earnings?
The current annual retained earnings of BCRX is -$1.68 B
What is the all time high annual retained earnings for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual retained earnings is -$21.50 M
What is BioCryst Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, BCRX annual retained earnings has changed by -$226.54 M (-15.57%)
What is BioCryst Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of BCRX is -$1.74 B
What is the all time high quarterly retained earnings for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly retained earnings is -$16.10 M
What is BioCryst Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, BCRX quarterly retained earnings has changed by -$123.82 M (-7.65%)